已收盘 12-19 16:00:00 美东时间
-1.180
-2.32%
今日重点评级关注:HC Wainwright & Co.:维持Oncolytics Biotech"买入"评级,目标价从5美元升至10美元;HC Wainwright & Co.:维持Barinthus Biotherapeutics"买入"评级,目标价从3美元升至4美元
11-18 15:28
B of A Securities analyst George Staphos upgrades Sylvamo (NYSE:SLVM) from Underperform to Buy and raises the price target from $41 to $59.
11-18 02:05
今日重点评级关注:Guggenheim:维持InflaRx"买入"评级,目标价从10美元升至22美元;巴克莱:维持Tandem糖尿病护理"超配"评级,目标价从51美元升至55美元
11-11 10:49
Sylvamo's board of directors unanimously adopted a limited-duration shareowner rights plan Monday to protect the interests of, and maximize value for, all shareowners. The rights plan is effective immediately.The board
11-11 05:26
RBC Capital analyst Matthew McKellar maintains Sylvamo (NYSE:SLVM) with a Sector Perform and raises the price target from $47 to $49.
11-11 00:06
Sylvamo (NYSE:SLVM) reported quarterly earnings of $1.44 per share which missed the analyst consensus estimate of $1.54 by 6.49 percent. This is a 40.98 percent decrease over earnings of $2.44 per share from the same
11-07 20:02
Companies Reporting Before The Bell • Kiora Pharmaceuticals (NASDAQ:KPRX) is pr...
11-07 19:11
The latest announcement is out from Sylvamo Corp ( ($SLVM) ). On October 27, 20...
10-29 18:59
NEW YORK, NY / ACCESS Newswire / September 16, 2025 / Sidoti Events, LLC, an af...
09-16 23:20
Sylvamo (NYSE:SLVM) declares $0.45/share quarterly dividend, in line with previous. Forward yield 4.16% Payable Oct. 17; for shareholders of record Oct. 3; ex-div Oct. 3. See SLVM Dividend Scorecard, ...
09-15 20:11